Get a quick look at 13 of the many FDA-approved drugs in 2023 for conditions commonly seen in primary care.
With 2023 at an end, Patient Care Online has compiled a list of key drugs approved by the US Food and Drug Administration (FDA) for conditions that are often seen in primary care. Scroll through the slides below to find details on a novel GIP and GLP-1 hormone mimetic indicated for chronic weight management; the first nonprescription daily oral contraceptive to be approved to prevent pregnancy; the first respiratory syncytial virus (RSV) vaccine for older adults; the first anti-inflammatory atheroprotective therapy for cardiovascular disease; and 9 more.
Can Colonoscopy Interval be Safely Extended from 10 to 15 Years for Individuals at Average CRC Risk?
May 3rd 2024New research suggests the interval "could potentially be extended" without significant harms and could reduce unnecessary invasive procedures. , ie, missed early detection and CRC-specific mortality.